Mutations in HIV-1 protease associated with resistance to amprenavir contribute towards phenotypic resistance to lopinavir

被引：0
|
作者：
Parkin, NT [1 ]
Chappey, C [1 ]
Petropoulos, CJ [1 ]
机构：
[1] ViroLogic, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
24
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Selective advantage of HIV protease mutations associated with resistance to lopinavir
    Molla, A.
    Lu, L.
    King, M.
    Woods, R.
    Pilot-Matias, T.
    Lam, E.
    Whitcomb, J.
    Bernstein, B.
    Hanna, G.
    Kempf, D.
    ANTIVIRAL THERAPY, 2007, 12 : S85 - S85
  • [2] Selective advantage of HIV protease mutations associated with resistance to lopinavir
    Molla, A.
    Lu, L.
    King, M.
    Woods, R.
    Pilot-Matias, T.
    Lam, E.
    Whitcomb, J.
    Bernstein, B.
    Hanna, G.
    Kempf, D.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S85 - S85
  • [3] Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50
    Mittal, Seema
    Bandaranayake, Rajinthna M.
    King, Nancy M.
    Prabu-Jeyabalan, Moses
    Nalam, Madhavi N. L.
    Nalivaika, Ellen A.
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF VIROLOGY, 2013, 87 (08) : 4176 - 4184
  • [4] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 : S144 - S144
  • [5] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92
  • [6] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S144 - S144
  • [7] Genotypic and phenotypic cross-resistance patterns to lopinavir and amprenavir in protease inhibitor-experienced patients with HIV viremia
    Paulsen, D
    Liao, QM
    Fusco, G
    St Clair, M
    Shaefer, M
    Ross, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (14) : 1011 - 1019
  • [8] Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir
    Parimal Kar
    Volker Knecht
    Journal of Computer-Aided Molecular Design, 2012, 26 : 215 - 232
  • [9] Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir
    Kar, Parimal
    Knecht, Volker
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (02) : 215 - 232
  • [10] Differential resistance in HIV-1 protease: the role of residue 50 in pathways for amprenavir/darunavir and atazanavir resistance
    Bandaranayake, R. M.
    Mittal, S.
    King, N. M.
    Prabu-Jeyabalan, M.
    Nalam, M. N. L.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2010, 15 : A14 - A14
12345